Valuation (43%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -11.53 | 27.20 |
| PEG Ratio (TTM) | 0.06 | 44.38 |
| P/S Ratio (TTM) | 3.55 | 7.33 |
| P/B Ratio (TTM) | 1.88 | 6.12 |
| P/FCF Ratio (TTM) | 9.83 | 23.05 |
| Price to 5YR AVG Earnings Ratio | N/A | 71.64 |
| Price to 5YR AVG FCF Ratio | N/A | 36.60 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -6.63% | 6.31% |
| ROE (TTM) | -15.27% | 20.05% |
| Net Profit Margin (TTM) | -30.57% | 7.71% |
| ROIC 5YR AVG | N/A | 11.85% |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -274.27% | -247.82% | N/A |
| Revenue | 45.79% | 16.03% | N/A |
| Net Income | -269.45% | -852.16% | N/A |
| Cash Flow | 520.72% | 7,722.76% | N/A |
Health (54%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.91 | 1.55 |
| Quick Ratio (TTM) | 2.95 | 1.12 |
| D/E Ratio (TTM) | 0.67 | 0.93 |
| Interest Coverage (TTM) | 1.81 | 14.34 |
| Piotroski F-Score | 6 | 7 |
| Altman Z-Score | 0.64 | 3.60 |
| LTL to 5YR AVG FCF | N/A | 6.66 |
| Shares Outstanding Growth 5YR AVG | N/A | 3.60% |